피부과 치료제 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 9.6%로 성장할 전망이며, 317억 5,000만 달러로 성장이 예측됩니다. 예측 기간의 성장은 생물제제 및 표적치료 진보, 원격 피부과학 및 디지털 헬스의 도입 확대, 생활습관과 관련된 피부질환 유병률 상승, 맞춤형 의료 및 재생 의료에 대한 수요 증가, 미생물 기반 피부과 치료에 대한 연구 확대에 기인할 것으로 보입니다. 이 기간에 예상되는 주요 동향으로는 나노기술을 이용한 약물 전달, AI를 활용한 피부과 진단, 미생물을 표적으로 한 치료, 피부 재생을 위한 3D 바이오프린팅, 유전자 편집, RNA를 이용한 치료 등이 있습니다.
미용 피부과 치료 수요 증가가 피부과 치료제 시장의 확대를 견인할 것으로 예측됩니다. 미용 피부과는 다양한 비외과적 치료와 처치를 통해 사람의 외모를 향상시키는 전문 분야입니다. 이러한 수요의 증가는 미용 치료에 대한 소비자 의식의 고조, 스킨케어 기술 진보, 외형을 개선하고 노화를 막기 위한 비침습적인 시술에 대한 기호 등이 배경에 있습니다. 안티에이징과 피부 회춘 등 미용 피부과 치료의 인기가 높아짐에 따라 안전하고 효과적이며 저침습적인 솔루션을 제공하는 선진적인 피부과 치료제 개발이 진행되고 있습니다. 예를 들어 2023년 1월 국제미용성형외과학회는 1,280만 건 이상의 외과적 수술과 1,750만 건 이상의 비외과적 수술이 전 세계적으로 진행돼 전기 대비 19.3% 증가했다고 보고했습니다. 이어 2022년에는 세계의 성형외과 의사들이 1,490만 건 이상의 외과 수술 및 1,880만 건 이상의 비외과 수술을 시행해 총 치료 건수가 11.2% 증가했습니다. 그 결과 미용 피부과 수술의 증가가 피부과 치료제 시장의 확대에 박차를 가하고 있습니다.
피부과 치료제 시장의 주요 기업은 건선, 아토피 피부염, 농포성 땀샘염 등의 만성 피부 질환에 대처하기 위한 생물학적 치료법의 개발에 주력하고 있습니다. 생물학적 제제는 특정 면역 경로를 표적으로 하며 기존 치료와 비교하여 보다 효과적이고 장기간에 걸친 완화를 제공합니다. 2024년 9월, 미국의 제약회사 일라이릴리 앤드 컴퍼니는, 12세 이상의 중등도로부터 중증의 아토피성 피부염 환자를 대상으로 한 인터루킨 13(IL-13) 저해약인 에브그리스(일반명 : 레브릭주맙)의 승인을 취득했습니다. 이번 승인은 외용 요법으로 충분한 증상 컨트롤을 얻을 수 없는 환자에게 생물학적 제제에 의한 새로운 치료 선택지를 제공하는 것으로 큰 진보입니다. 에브그리스는 중등증에서 중증 아토피 피부염에 동반되는 강한 가려움 및 피부 염증을 억제함으로써 환자의 삶의 질 향상을 목표로 합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장-거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
- 세계의 피부과 치료제 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
- 최종 이용 산업의 분석
- 세계의 피부과 치료제 시장 : 성장률 분석
- 세계의 피부과 치료제 시장 실적 : 규모 및 성장(2019-2024년)
- 세계의 피부과 치료제 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
- 세계의 피부과 치료제 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 피부과 치료제 시장 : 약제 클래스별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 코르티코스테로이드
- 레티노이드
- 항생제
- 항진균제
- 칼시뉴린 억제제
- 기타 약물 클래스
- 세계의 피부과 치료제 시장 : 관리국별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 국소 투여
- 경구 투여
- 비경구 투여
- 세계의 피부과 치료제 시장 : 적응증별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 여드름
- 건선
- 술사양 피부염
- 탈모증
- 기타 적응증
- 세계의 피부과 치료제 시장 : 유통 채널별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 병원 약국
- 소매 약국
- 기타 유통 채널
- 세계의 피부과 치료제 시장 : 코르티코스테로이드 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 국소 코르티코스테로이드
- 경구 코르티코스테로이드
- 주사용 코르티코스테로이드
- 세계의 피부과 치료제 시장 : 레티노이드 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 국소 레티노이드
- 경구 레티노이드
- 세계의 피부과 치료제 시장 : 항생제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 국소 항생제
- 경구 항생제
- 세계의 피부과 치료제 시장 항진균제유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 국소 항진균제
- 경구 항진균제
- 세계의 피부과 치료제 시장 : 칼시뉴린 억제제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 국소 칼시뉴린 억제제
- 전신성 칼시뉴린 억제제
- 세계의 피부과 치료제 시장 : 기타 약물 클래스 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 생물학적 제형
- JAK 억제제
- 항히스타민제
- 광선역학요법제
제7장 지역별 및 국가별 분석
- 세계의 피부과 치료제 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 피부과 치료제 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
- 피부과 치료제 시장 : 경쟁 구도
- 피부과 치료제 시장 : 기업 프로파일
- Pfizer Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Johnson & Johnson Services Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- AbbVie Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Bayer AG 개요, 제품 및 서비스, 전략 및 재무 분석
- AstraZeneca plc 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Novartis AG
- GlaxoSmithKline Plc
- Eli Lilly and Company
- Amgen Inc.
- Bausch Health Companies Inc.
- Organon International
- Galderma
- Incyte Corporation
- Glenmark Pharmaceuticals Ltd.
- Mayne Pharma Group Limited
- Dermavant Sciences Inc.
- Taro Pharmaceutical Industries Ltd.
- Biofrontera AG
- Almirall SA
- UCB SA
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
- 피부과 치료제 시장(2029년) : 새로운 기회를 제공하는 국가
- 피부과 치료제 시장(2029년) : 새로운 기회를 제공하는 부문
- 피부과 치료제 시장(2029년) : 성장 전략
제36장 부록
AJY
Dermatological drugs are medications formulated to treat conditions affecting the skin, hair, and nails by reducing inflammation, controlling infections, and managing symptoms such as itching and redness. These drugs are essential in dermatology, helping to address both common and severe skin disorders while enhancing patient comfort and quality of life.
The primary drug classes in dermatological treatments include corticosteroids, retinoids, antibiotics, antifungals, calcineurin inhibitors, and others. Corticosteroids are a class of steroid hormones that reduce inflammation and suppress immune system activity by mimicking cortisol, a natural hormone produced by the adrenal glands. These drugs can be administered through various routes, including topical, oral, and parenteral administration. They are used to treat multiple conditions such as acne, psoriasis, rosacea, alopecia, and more. Distribution channels include hospital pharmacies, retail pharmacies, and other outlets.
The dermatological drugs market research report is one of a series of new reports from The Business Research Company that provides dermatological drugs market statistics, including dermatological drugs industry global market size, regional shares, competitors with a dermatological drugs market share, detailed dermatological drugs market segments, market trends and opportunities, and any further data you may need to thrive in the dermatological drugs industry. This dermatological drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The dermatological drugs market size has grown strongly in recent years. It will grow from $20.06 billion in 2024 to $22.04 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth during the historic period was driven by the rising prevalence of skin disorders, advancements in drug formulation and delivery, increasing awareness of skincare and aesthetics, the expansion of the aging population, and the growing demand for over-the-counter dermatological products.
The dermatological drugs market size is expected to see strong growth in the next few years. It will grow to $31.75 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The projected growth in the forecast period can be attributed to advancements in biologics and targeted therapies, the increasing adoption of teledermatology and digital health, a rising prevalence of lifestyle-related skin conditions, growing demand for personalized and regenerative medicine, and expanding research in microbiome-based dermatological treatments. Key trends expected in this period include nanotechnology-based drug delivery, AI-driven dermatological diagnostics, microbiome-targeted therapies, 3D bioprinting for skin regeneration, gene editing, and RNA-based treatments.
The increasing demand for cosmetic dermatology procedures is expected to drive the expansion of the dermatological drugs market. Cosmetic dermatology is a specialized field that enhances a person's appearance through various non-surgical treatments and procedures. This growing demand is fueled by heightened consumer awareness of aesthetic treatments, advancements in skincare technology, and a preference for non-invasive procedures to improve appearance and counteract aging. The rising popularity of cosmetic dermatology treatments, such as anti-aging and skin rejuvenation procedures, is leading to the development of advanced dermatological drugs that provide safe, effective, and minimally invasive solutions. For example, in January 2023, the International Society of Aesthetic Plastic Surgery reported that over 12.8 million surgical and 17.5 million non-surgical procedures were performed globally, reflecting a 19.3% increase from the previous period. Additionally, in 2022, plastic surgeons worldwide conducted more than 14.9 million surgical and 18.8 million non-surgical procedures, marking an 11.2% rise in total treatments. As a result, the growing number of cosmetic dermatology procedures is fueling the expansion of the dermatological drugs market.
Leading companies in the dermatological drugs market are focusing on developing biologic treatments to address chronic skin conditions such as psoriasis, atopic dermatitis, and hidradenitis suppurativa. Biologic therapies target specific immune pathways, offering more effective and long-lasting relief compared to traditional treatments. In September 2024, Eli Lilly and Company, a US-based pharmaceutical firm, received approval for Ebglyss (lebrikizumab), an interleukin-13 (IL-13) inhibitor designed to treat moderate-to-severe atopic dermatitis in patients aged 12 and older. This approval represents a significant advancement, providing a new biologic treatment option for individuals who have not achieved sufficient symptom control with topical therapies. Ebglyss aims to enhance patients' quality of life by reducing severe itching and skin inflammation associated with moderate-to-severe atopic dermatitis.
In September 2024, Organon, a US-based pharmaceutical company, acquired Dermavant Sciences Ltd. for $1.2 billion. This acquisition brings Dermavant's flagship product, VTAMA (tapinarof) cream, 1%, into Organon's portfolio. VTAMA is a non-steroidal topical treatment approved by the US Food and Drug Administration (FDA) for mild, moderate, and severe plaque psoriasis in adults. Dermavant Sciences Ltd. is a US-based immunodermatology company specializing in the development and commercialization of innovative dermatological treatments.
Major players in the dermatological drugs market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc., Bayer AG, AstraZeneca plc, Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Bausch Health Companies Inc., Organon International, Galderma, Incyte Corporation, Glenmark Pharmaceuticals Ltd., Mayne Pharma Group Limited, Dermavant Sciences Inc., Taro Pharmaceutical Industries Ltd., Biofrontera AG, Almirall SA, UCB SA, LEO Pharma A/S, and Dermira Inc.
North America was the largest region in the dermatological drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in dermatological drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the dermatological drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The dermatological drugs market consists of sales of creams, ointments, gels, and lotions. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Dermatological Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on dermatological drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for dermatological drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dermatological drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Drug Class: Corticosteroids; Retinoids; Antibiotics; Antifungals; Calcineurin Inhibitors; Other Drug Classes
- 2) By Administration: Topical Administration; Oral Administration; Parenteral Administration
- 3) By Indication: Acne; Psoriasis; Rosacea; Alopecia; Other Indications
- 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
- Subsegments:
- 1) By Corticosteroids: Topical Corticosteroids; Oral Corticosteroids; Injectable Corticosteroids
- 2) By Retinoids: Topical Retinoids; Oral Retinoids
- 3) By Antibiotics: Topical Antibiotics; Oral Antibiotics
- 4) By Antifungals: Topical Antifungals; Oral Antifungals
- 5) By Calcineurin Inhibitors: Topical Calcineurin Inhibitors; Systemic Calcineurin Inhibitors
- 6) By Other Drug Classes: Biologics; JAK Inhibitors; Antihistamines; Photodynamic Therapy Agents
- Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; AbbVie Inc.; Bayer AG; AstraZeneca plc
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Dermatological Drugs Market Characteristics
3. Dermatological Drugs Market Trends And Strategies
4. Dermatological Drugs Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Dermatological Drugs Growth Analysis And Strategic Analysis Framework
- 5.1. Global Dermatological Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Dermatological Drugs Market Growth Rate Analysis
- 5.4. Global Dermatological Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Dermatological Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Dermatological Drugs Total Addressable Market (TAM)
6. Dermatological Drugs Market Segmentation
- 6.1. Global Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Corticosteroids
- Retinoids
- Antibiotics
- Antifungals
- Calcineurin Inhibitors
- Other Drug Classes
- 6.2. Global Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Topical Administration
- Oral Administration
- Parenteral Administration
- 6.3. Global Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Acne
- Psoriasis
- Rosacea
- Alopecia
- Other Indications
- 6.4. Global Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Other Distribution Channels
- 6.5. Global Dermatological Drugs Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Topical Corticosteroids
- Oral Corticosteroids
- Injectable Corticosteroids
- 6.6. Global Dermatological Drugs Market, Sub-Segmentation Of Retinoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Topical Retinoids
- Oral Retinoids
- 6.7. Global Dermatological Drugs Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Topical Antibiotics
- Oral Antibiotics
- 6.8. Global Dermatological Drugs Market, Sub-Segmentation Of Antifungals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Topical Antifungals
- Oral Antifungals
- 6.9. Global Dermatological Drugs Market, Sub-Segmentation Of Calcineurin Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Topical Calcineurin Inhibitors
- Systemic Calcineurin Inhibitors
- 6.10. Global Dermatological Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Biologics
- JAK Inhibitors
- Antihistamines
- Photodynamic Therapy Agents
7. Dermatological Drugs Market Regional And Country Analysis
- 7.1. Global Dermatological Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Dermatological Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Dermatological Drugs Market
- 8.1. Asia-Pacific Dermatological Drugs Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Dermatological Drugs Market
- 9.1. China Dermatological Drugs Market Overview
- 9.2. China Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Dermatological Drugs Market
- 10.1. India Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Dermatological Drugs Market
- 11.1. Japan Dermatological Drugs Market Overview
- 11.2. Japan Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Dermatological Drugs Market
- 12.1. Australia Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Dermatological Drugs Market
- 13.1. Indonesia Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Dermatological Drugs Market
- 14.1. South Korea Dermatological Drugs Market Overview
- 14.2. South Korea Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Dermatological Drugs Market
- 15.1. Western Europe Dermatological Drugs Market Overview
- 15.2. Western Europe Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Dermatological Drugs Market
- 16.1. UK Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Dermatological Drugs Market
- 17.1. Germany Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Dermatological Drugs Market
- 18.1. France Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Dermatological Drugs Market
- 19.1. Italy Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Dermatological Drugs Market
- 20.1. Spain Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Dermatological Drugs Market
- 21.1. Eastern Europe Dermatological Drugs Market Overview
- 21.2. Eastern Europe Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Dermatological Drugs Market
- 22.1. Russia Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Dermatological Drugs Market
- 23.1. North America Dermatological Drugs Market Overview
- 23.2. North America Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Dermatological Drugs Market
- 24.1. USA Dermatological Drugs Market Overview
- 24.2. USA Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Dermatological Drugs Market
- 25.1. Canada Dermatological Drugs Market Overview
- 25.2. Canada Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Dermatological Drugs Market
- 26.1. South America Dermatological Drugs Market Overview
- 26.2. South America Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Dermatological Drugs Market
- 27.1. Brazil Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Dermatological Drugs Market
- 28.1. Middle East Dermatological Drugs Market Overview
- 28.2. Middle East Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Dermatological Drugs Market
- 29.1. Africa Dermatological Drugs Market Overview
- 29.2. Africa Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Dermatological Drugs Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Dermatological Drugs Market Competitive Landscape And Company Profiles
- 30.1. Dermatological Drugs Market Competitive Landscape
- 30.2. Dermatological Drugs Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
31. Dermatological Drugs Market Other Major And Innovative Companies
- 31.1. Novartis AG
- 31.2. GlaxoSmithKline Plc
- 31.3. Eli Lilly and Company
- 31.4. Amgen Inc.
- 31.5. Bausch Health Companies Inc.
- 31.6. Organon International
- 31.7. Galderma
- 31.8. Incyte Corporation
- 31.9. Glenmark Pharmaceuticals Ltd.
- 31.10. Mayne Pharma Group Limited
- 31.11. Dermavant Sciences Inc.
- 31.12. Taro Pharmaceutical Industries Ltd.
- 31.13. Biofrontera AG
- 31.14. Almirall SA
- 31.15. UCB SA
32. Global Dermatological Drugs Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Dermatological Drugs Market
34. Recent Developments In The Dermatological Drugs Market
35. Dermatological Drugs Market High Potential Countries, Segments and Strategies
- 35.1 Dermatological Drugs Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Dermatological Drugs Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Dermatological Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
